创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: iHuPBMC-B Platform Main Features

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-03-26 13:35
  • Views:

(Summary description)The iHuPBMC-B platform launched by InnoModels Biotechnology is gradually becoming an important tool for cell biology research due to its unique technical features, wide range of application areas and excellent scientific value.

InnoModels Biotechnology: iHuPBMC-B Platform Main Features

(Summary description)The iHuPBMC-B platform launched by InnoModels Biotechnology is gradually becoming an important tool for cell biology research due to its unique technical features, wide range of application areas and excellent scientific value.

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-03-26 13:35
  • Views:
Information

The iHuPBMC-B platform launched by InnoModels Biotechnology is gradually becoming an important tool for cell biology research due to its unique technical features, wide range of application areas and excellent scientific value.
1. Highly reproducible human environment
One of the core advantages of iHuPBMC-B platform is its highly reproducible human environment. The platform utilizes advanced cell culture technology and precise regulatory tools to simulate the complex physiological environment in the human body, including cell-cell interactions, signal transduction, and so on. This enables researchers to more realistically simulate and study cell biological processes in the human body in an in vitro environment.
2. Diverse cell types
The iHuPBMC-B platform provides a diverse selection of cell types. Researchers can choose different types of cells for culture and research according to their experimental needs. This not only broadens the scope of research, but also provides researchers with a more flexible choice of cell models.
3. Efficient cell culture and screening technology
The iHuPBMC-B platform adopts highly efficient cell culture and screening technologies. By optimizing cell culture conditions and improving cell viability and activity, the platform is able to quickly screen cells that meet experimental requirements, greatly improving the efficiency and success rate of experiments.

 


4. Reliable data support and reproducibility
InnoModels Biotechnology focuses on the reliability of data and repeatability of experiments. iHuPBMC-B platform has gone through strict experimental validation and data analysis during the design and development process to ensure the accuracy and reliability of experimental results. This provides solid data support for researchers and promotes the transformation and application of research results.
5. Wide range of application areas
The iHuPBMC-B platform has a wide range of applications. Whether in drug screening, disease simulation or basic cell biology research, the platform can provide strong support for researchers. It can not only be used to evaluate the efficacy and safety of drugs, but also simulate the occurrence and development of diseases, providing important clues for the research and treatment of diseases.
6. Strong technical support and services
InnoModels Biotechnology provides strong technical support and high quality service. From platform use to data analysis, the company can provide comprehensive help and support for researchers. This provides researchers with great convenience and protection when using the iHuPBMC-B platform.
Conclusion
The iHuPBMC-B platform of InnoModels Biotechnology is becoming an important tool for cell biology research with its highly restored human environment, diverse cell type selection, efficient cell culture and screening technology, reliable data support and reproducibility, wide range of application areas, and strong technical support and services. With the continuous development and improvement of the platform, we have reason to believe that it will play an even more important role in future cell biology research and make greater contributions to the cause of human health.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司